Filters: press-releases




20160128 EGA Regulatory and Scientific Affairs Conferenc

Statement in response to the EU Council ratifying the Brexit transition deal

23 March 2018

Today’s agreement on a transition period is welcome news for […]

Read more

European health community issues key questions Article 50 negotiations must answer for patients and public health

8 March 2018

The European Health Community has warned that time is running […]

Read more

Supply chain commitment to tackling problem of medicine shortages

2 March 2018


IGBA launches a biosimilar medicines information campaign

1 February 2018


IGBA congratulates the Australian government for maintaining their biologics naming convention and for strengthening pharmacovigilance

29 January 2018


2018 – A year of unprecedented challenges and opportunities for pharmaceutical regulatory systems

25 January 2018

This week in London, Medicines for Europe gathers regulators and […]

Read more

Vigilance saves lives! More focus needed on sustainability and patient engagement

24 January 2018

National authorities, regulators, industry leaders and key stakeholders gathered in […]

Read more

Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come

18 January 2018

Geneva, 18 January 2018 – Today, the AMR Industry Alliance […]

Read more

The associations representing the European and British life science industry (AESGP, ABPI, BGMA, BIA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union

14 December 2017

Today, organisations representing the life science industry in the EU […]

Read more

European Commission launches: “What I need to know about Biosimilar Medicines – Information for patients”, in 23 EU languages

29 November 2017

The European Commission launched today additional translations of the Q&A […]

Read more

Subscribe to our newsletter